text:
Results 1 to 6 of 6
Thread: My baby still have no teeth
12th September 2013 02:13 PM #1
- Join Date
- Sep 2013
- Posts
- 12
My baby still have no teeth
hi there,I have 11 months old baby boy and still he doesn't have any sign oh having teeth.Please help me about this I'm worried.Is this something I need to do?
15th September 2013 05:33 AM #2
It's normal for the first tooth to appear at anything up to 12-13 months of age. Please try not to worry - it doesn't mean anything is wrong. Children just develop at different times.
If he doesn't have any sign of a tooth a little after his first birthday then it would be good just to check with your doctor. It's most likely that everything will be fine; he may just get lots of teeth in one go!
Best wishes,
15th September 2013 09:28 AM #3
- Join Date
- Sep 2013
- Posts
- 12
Thank you Lj it really help to ease my worry.Maybe I'm just exited for his teet.
16th September 2013 06:29 AM #4
I'm glad my comments have helped.
I think your feelings are understandable as a parent of a baby. I have found that we often want our children to stay as babies/ toddlers forever but at the same time it can be hard to not have concerns about them reaching the next stage. I find it helpful to hold in mind that our children are all unique and develop at their own rate; it is unusual for there to be a developmental problem. We live in a world full of targets, measurements, growth charts and averages but children will still be children and they will develop to the next stage when they are ready.
Please do post back if you have any more concerns.
Best wishes,
16th September 2013 01:29 PM #5
- Join Date
- Sep 2013
- Posts
- 12
You're right Lj
As a first time mum at the age of 22 I'm always looking for his development day by day.I always want him to be in normal stage of development like now, he learn how to walk just a two step and I'm so glad to that.
Thank you for a very good advice and support too.
17th September 2013 05:56 AM #6
My youngest has recently started taking his first steps too - proud mummy moments


text:
Dalton Hilliard is sticking with his father Larry's story. He was named after the former New Orleans Saints star running back, and that's that.
Hilliard's mother Amalia, however, recalls another story.
"I was very pregnant and I was down to two names," Amalia said. "I remember I was watching the movie `Road House.' Patrick Swayze played this tough, no-nonsense guy who kicks butt."
The character Swayze played is James Dalton, a smooth yet intimidating bouncer who wreaks of charm and swag.
"I chose Dalton because of that," Amelia said.
It turns out Hilliard is a perfect blend of both versions.
He's a Swiss Army knife. A five-tool player with the kind of versatility on which UCLA coach Jim Mora is capitalizing. Hilliard, a senior, came to UCLA as a running back, switched to safety, and now plays inside linebacker.
He's more than embraced the move, he's thrived playing important downs on defense whether the Bruins are in their nickel, dime or base package.
Hilliard can play virtually anywhere. He can blitz. He can drop into coverage, and he's become a solid run defender.
Yes, he's kicking butt.
"I know this term gets thrown around a lot, but he's a football player," UCLA linebackers coach Jeff Ulbrich said. "For a guy who has played his entire life in the secondary and offensively in the backfield, he's done an amazing job picking it up."
Hilliard comes from a long lineage of family members who played football. It's why he's often confused as the son of the former New Orleans Saints running back.
"All the time," Hilliard said.
In reality, that Hilliard is a distant relative. Like a third uncle.
"I have a long list of family members that I've never met who played football," Hilliard said.
But the ones who made an immediate and long-lasting impact were closer to home.
His father, a major in the U.S. Marine Corps, was a star safety at Eastern New Mexico who earned tryouts with the Dallas Cowboys and New York Giants before blowing out every ligament in his knee. But the fact he didn't make it to the pros didn't change the way Hilliard viewed his father.
"He was a baller," he said. "I've seen tape of him just killing guys coming downhill and juking guys when he was on offense."
Hilliard's father played running back, wide receiver and defensive back in high school. Hilliard followed in his father's steps, playing the same positions at Punahou High in Hawaii. He also wore No. 4, the same number his father donned in college.
"He was one heck of a player," Hilliard said. "He's my inspiration."
Hilliard holds his mother in high regard, too. She's an executive at an engineering firm, but she also played professional football with the New York Sharks of the Women's Professional Football League.
"The running joke in my family is I'm the only professional player," Amalia said via phone from Seoul, South Korea. "I'm hoping and praying that my son gets to break that tradition."
Hilliard remembers growing up watching his mother at practice while tossing the football with his brother, and he grew to respect the women who played such a beautiful but brutal sport.
"He saw that they can do anything that they want to be," Amalia said. "It's not powder puff. These are women are out there in pads."
And Hilliard found his own way of paying homage to his mother.
"In high school I wore her game pads," said Hilliard, who had a career-high three tackles for a loss at Colorado. "Her pads were kind of small. So I said, `I'll go ahead and use these ones because the smaller the pads the faster you run."'
Larry was versatile in high school. And Amalia was no different, playing tight end, linebacker and some nose tackle.
"When we lived in New York," Hilliard recalls, "Hofstra (University) was about a mile away from my house where they practiced. Most people can't say their mom, of all people, played professional football. She's one heck of a woman."
Amalia was discovered during a clinic held by the New York Jets for women who wanted to learn more about the sport. Amalia played quarterback and receiver during seven-on-seven drills. The owner of the New York Sharks was there and approached her about playing.
Amalia, a full-time accounting manager at the time, was 32 when she joined the team. Dalton was in the fourth grade and younger brother Kamdon was in first grade. Paige was a newborn still in a stroller. After work, Amalia attended two-hour practices and played games on the weekend.
It was by chance that Amalia was able to join. The Hilliards spent time in Illinois, California, Virginia and North Carolina before moving to New York following Larry's work with the Marines.
The Hilliards were in New York when the terrorist attack on the World Trade Center happened. The Sharks, who played only 10 miles from Ground Zero, postponed their games, but Larry went to work.
He was stationed in New York as a company commander training Marine reservists. After 9/11, the military activated the reservists and Larry led the charge supporting communications through Satellite radio.
The Sharks' season resumed nearly a month later. Amalia's season was cut short when she suffered a torn MCL in Arizona. The Hilliards eventually moved to Hawaii, where they live to this day.
Larry retired after serving two decades in the Marines.
"He's living the dream," Hilliard said.
And maybe he can say the same when his time ends at UCLA and just maybe continues in the NFL. He's not thinking ahead, as UCLA is in the middle of what could be a promising season.
But his versatility will only help his chances.
"I love the fact I can play so many positions on this team and coaches trusting me to learn the playbook at those positions," Hilliard said. "It's really something that I'm enjoying."
There's no debating now.
Hilliard's all football.
And swag.

subset: commoncrawl


text:
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
This study is currently recruiting participants.
Verified December 2016 by Patricia Kissinger, Tulane University Health Sciences Center
Tulane University Health Sciences Center
Information provided by (Responsible Party):
Patricia Kissinger, Tulane University Health Sciences Center
ClinicalTrials.gov Identifier:
First received: April 4, 2013
Last updated: December 16, 2016
Last verified: December 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Detailed Description:
The overall goal of this project is to determine the influence of patient treatment and host factors on repeat Trichomonas vaginalis (TV) infections among HIV-negative women
|Vaginitis Trichomonal or Due to Trichomonas
|Drug: MTZ 500 mg BID x 7 days Drug: MTZ 2 g
|Phase 3
|Study Type:
|Study Design:
|Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:
|Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
Resource links provided by NLM:
MedlinePlus related topics: HIV/AIDSU.S. FDA Resources
Further study details as provided by Patricia Kissinger, Tulane University Health Sciences Center:
Primary Outcome Measures:
- TV negative after treatment with either multi or single dose MTZ [ Time Frame: 4 weeks post treatment completion ]
|Estimated Enrollment:
|Study Start Date:
|June 2013
|Estimated Study Completion Date:
|December 2017
|Estimated Primary Completion Date:
|December 2017 (Final data collection date for primary outcome measure)
|Assigned Interventions
Active Comparator: MTZ 2 g
Single dose MTZ
Drug: MTZ 2 g
MTZ 2 g
Other Name: Single dose MTZ
Experimental: MTZ 500 mg BID x 7 days
Multi dose MTZ
Drug: MTZ 500 mg BID x 7 days
MTZ 500 mg BID x 7days
Other Name: Multi-dose MTZ
Detailed Description:
This study is a phase III randomized clinical trial. HIV-negative women who test positive for TV at their routine gynecological exam at participating clinics will be referred to the nurse/study coordinator to screen for eligibility, provide a description of the study, and obtain written, informed consent (N=700). Subjects will undergo an audio computer assisted self- interview (ACASI), and will self-collect vaginal swabs for Trichomonas testing by InPouch and NAAT, Gram stain testing, and a future microbiome specimen. They will be randomized into one of two arms; metronidazole (MTZ) 2 g single dose (CDC recommended treatment regimen) or MTZ 500 mg BID 7-day dose (CDC alternative treatment regimen). All enrolled women will be scheduled for a follow-up visit at four weeks post treatment completion (window 3-13 weeks).
|Ages Eligible for Study:
|18 Years and older (Adult, Senior)
|Sexes Eligible for Study:
|Accepts Healthy Volunteers:
Inclusion Criteria:
- female
- English speaking
- >= 18 years old
Exclusion Criteria:
- HIV-infected
- unable to provide informed consent
- pregnant
- breast feeding
- treated by their provider for BV at visit
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01832480
Please refer to this study by its ClinicalTrials.gov identifier: NCT01832480
|Contact: Patricia Kissinger, PhD
|United States, Alabama
|Jefferson County Dept of Health/STD Specialty Clinic
|Birmingham, Alabama, United States, 35233
|Contact: Christina Muzny, MD 205-975-3298 firstname.lastname@example.com
|Principal Investigator: Christina Muzny, MD
|Sub-Investigator: Jane Schwebke, MD
|United States, Louisiana
|CrescentCare Health and Wellness Center
|New Orleans, Louisiana, United States, 70119
|Contact: Rebecca Lillis, MD firstname.lastname@example.com
|Sub-Investigator: Stephanie N Taylor, MD
|Principal Investigator: Rebecca Lillis, MD
|United States, Mississippi
|Crossroads Clinic
|Active, not recruiting
|Jackson, Mississippi, United States, 39213
Sponsors and Collaborators
Tulane University Health Sciences Center
|Principal Investigator:
|Patricia Kissinger, MD
|Tulane Univeristy
More Information
Keywords provided by Patricia Kissinger, Tulane University Health Sciences Center:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 25, 2017
Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009 Jan;36(1):11-6. doi: 10.1097/OLQ.0b013e318186decf.
Kissinger P, Secor WE, Leichliter JS, Clark RA, Schmidt N, Curtin E, Martin DH. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis. 2008 Apr 1;46(7):994-9. doi: 10.1086/529149.
Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, Meadors B, Sanders C, Farley TA. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis. 2006 Jul;33(7):445-50.
Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, Schmidt N, Rosenthal SL, Myers L, Martin DH. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):565-71. doi: 10.1097/QAI.0b013e3181eda955.
Howe K, Kissinger PJ. Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis. Sex Transm Dis. 2017 Jan;44(1):29-34.
Meites E, Gaydos CA, Hobbs MM, Kissinger P, Nyirjesy P, Schwebke JR, Secor WE, Sobel JD, Workowski KA. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections. Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S837-48. doi: 10.1093/cid/civ738. Review.
|Responsible Party:
|Patricia Kissinger, Professor, Tulane University Health Sciences Center
|ClinicalTrials.gov Identifier:
|NCT01832480 History of Changes
|Other Study ID Numbers:
|Study First Received:
|April 4, 2013
|Last Updated:
|December 16, 2016
|Individual Participant Data (IPD) Sharing Statement:
|Plan to Share IPD:
Keywords provided by Patricia Kissinger, Tulane University Health Sciences Center:
Trichomonas vaginalis
Additional relevant MeSH terms:
Trichomonas Infections
Trichomonas Vaginitis
Vaginal Diseases
Genital Diseases, Female
Protozoan Infections
Parasitic Diseases
ClinicalTrials.gov processed this record on July 25, 2017


text:
Bookmark this site
DENVER, CO -- Marley Coffee has appointed two industry veterans to direct the company's sales force. Russ Stange has been named director of sales for the West Coast and Chris Mamos will serve as East Coast sales director.
Stange most recently served as senior account manager at KeHE Distributors Inc., an Illinois-based grocery distribution chain.
Mamos is the former director of national accounts at Marley Beverage. He previously worked as national account executive and regional key account manager at Fiji Water.
Marley Coffee chief executive Brent Toevs said Stange apply his background in the natural grocery channel to increasing Marley Coffee's presence in that sector. He added that the company similarly will leverage Mamos's experience opening and building big accounts.


text: Is it the single most famous porn film of all time? Yes, without even the slightest of doubts. DeepThroat has been the focus of many documentaries, books and attempted sequels but nothing has ever captured the magic of porn movie fame quite like the one and only original film starring Linda Lovelace and a cast of characters that are now part of the permanent pop-culture XXX zeitgeist!Show more